Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts

Abstract

Industry payments to physicians are associated with higher rates of prescribing brand-name statins. As the United States seeks to rein in the costs of prescription drugs and make them less expensive for patients, our findings are concerning.